CeriXClinic Aalborg No1 ApS: Financial statements 2019
CVR: 39659379
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CeriXClinic Aalborg No1 ApS (CVR 39659379) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,635,249 and a net result of DKK 952,298. Equity in the 2019 report amounted to DKK 1,265,644. The solvency ratio was 39.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,635,249
- Profit/Loss
- DKK 952,298
- Equity
- DKK 1,265,644
- Total Assets
- DKK 3,220,613
- Employees
- 3
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CeriXClinic Aalborg No1 ApS has published its interim report for the period June 21, 2018 to December 31, 2018.
As of May 1, 2019, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of CeriXClinic Aalborg No1 ApS.
On January 18, 2019, the company changed its name from CeriXCliniC Aalborg NO1 ApS to CeriXClinic Aalborg No1 ApS.
About CeriXClinic Aalborg No1 ApS
CeriXClinic Aalborg No1 ApS was a Danish company of the type Anpartsselskab based in Aalborg, founded in 2018. The company has been dissolved on 1 August 2024. The company was registered under the industry Praktiserende speciallæger. The company was previously named CeriXCliniC Aalborg NO1 ApS. The company has 10 employees (2024). In 2023, the company reported a gross profit of DKK 1,237,998 and a net result of DKK -2,520,200 compared with DKK -1,886,433 the year before. Equity in the 2023 report amounted to DKK -3,902,184.
